Questcor Pharmaceuticals (QCOR -7.3%) takes a hit today on reports that Cerium Pharmaceuticals...

|By:, SA News Editor

Questcor Pharmaceuticals (QCOR -7.3%) takes a hit today on reports that Cerium Pharmaceuticals has been granted an FDA orphan drug designation for Synacthen Depot, a synthetic equivalent of Acthar.